Featured Research

from universities, journals, and other organizations

Being Fat Needn't Be All Bad News

Date:
August 27, 2007
Source:
Journal of Clinical Investigation
Summary:
Many individuals become type 2 diabetics because the cells of their body no longer respond to insulin. It is thought that one reason over eating causes insulin resistance is that fat is deposited in organs of the body, such as the liver, rather than in the fat tissue.

Many individuals become type 2 diabetics because the cells of their body no longer respond to insulin.

It is thought that one reason over eating causes insulin resistance is that fat is deposited in organs of the body, such as the liver, rather than in the fat tissue. This idea is now supported by the work of Phillip Scherer and colleagues at Albert Einstein College of Medicine, New York, who have shown that insulin resistance in mice is not determined by how fat they are but rather where the fat is stored.

Mice that are obese because they lack leptin (ob/ob mice) become insulin resistant. In the new study, researchers show that if ob/ob mice are engineered to express adiponectin they do not become insulin resistant.

However, these mice were morbidly obese and the mass of their fat tissues was much increased compared with normal ob/ob mice. The authors therefore suggest that an inability to maintain high levels of adiponectin might be what causes insulin resistance in individuals who over eat because it would mean that the excess food they consume is stored in regions of the body other than the fat tissues.

Article: Obesity-associated improvements in metabolic profile through expansion of adipose tissue


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Being Fat Needn't Be All Bad News." ScienceDaily. ScienceDaily, 27 August 2007. <www.sciencedaily.com/releases/2007/08/070823213652.htm>.
Journal of Clinical Investigation. (2007, August 27). Being Fat Needn't Be All Bad News. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/08/070823213652.htm
Journal of Clinical Investigation. "Being Fat Needn't Be All Bad News." ScienceDaily. www.sciencedaily.com/releases/2007/08/070823213652.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins